| Name | Title | Contact Details |
|---|
OREX Computed Radiography A Kodak Company is a Auburndale, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Hermes Medical Solutions is a Chicago, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
XACT Robotics® is a privately held company focused on advancing the field of radiology by developing the world`s first and only hands-free robotic solutions that can significantly improve targeting accuracy, efficiency, and consistency in percutaneous radiology procedures. The company was founded in 2013 by Harel Gadot, a renowned entrepreneur in the MedTech robotics space, whose vision reimagined how image-guided percutaneous procedures are performed. At XACT, we embrace the philosophy of collaboration, tenacity, and extreme ownership. Our family culture empowers and inspires as we partner, develop, and execute meaningful technologies to make a difference in the lives of patients. Our company`s leadership is comprised of start-up, robotic, and disruptive technology experts with deep knowledge, vast experience and the diverse leadership skills required in the robotic market.
Reliable Medical Supply is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
InfraScan, Inc. is a medical device company that focuses on developing, commercializing, and distributing hand-held diagnostic devices for head injury and stroke assessment based on near infrared (NIR) technology. The Infrascanner enables clinicians to detect effectively, conveniently, and accurately intracranial bleeding in patients with head trauma. Intracranial hematomas are an important treatable cause of secondary brain injury in patients with head trauma. Recent statistics from Iraq shows that 30% of all wounded in action have head injuries; of them 40% have brain hematomas. Dr. Britton Chance (University of Pennsylvania) and Dr. Claudia Robertson (Baylor College of Medicine) invented a NIR system for detection of brain Hematomas and tested it successfully in 305 patients in Baylor. An entrepreneurial team formed a company around this technology in Collaboration with Drexel University and won the Wharton Business Plan competition in April 2004 and the second prize at the global business plan competition in Singapore in October 2004. Office of Naval Research funded the company in May 2004. The company also attracted $1.5M in funding from BioAdvance, the Biotechnology Greenhouse of Southeastern Pennsylvania, from Ben Franklin Technology Partners of Southeastern Pennsylvania, and from Philadelphia Industrial Development Corporation. A multicenter clinical study to support an FDA submission started in July 2006, and on February 2008 an application was submitted to the FDA. After 4 years of review, the FDA cleared Infrascanner Model 1000 as a DeNovo medical technology in December 2011. In January 2013 the FDA cleared the 510(k) of Infrascanner Model 2000.